TNI BioTech, Inc. Signs Non-Exclusive Distribution Agreement for Lodonal™ for Cancer and Receives First Sale in Africa

ORLANDO, Fla. and DUBLIN, June 25, 2014 /PRNewswire/  TNI BioTech, Inc. (OTC-TNIB) ( TNI BioTech ) is pleased to announce that its pharmaceutical sales division, Airmed Biopharma Limited, ( Airmed ), a wholly owned Irish Company, has signed a non-exclusive distribution agreement with PanAm Global Logistics, Inc. ( PanAm ) to market Lodonal™. TNI BioTech had received approval for Lodonal™ from the Republic of Malawi and with that approval Airmed has signed a distribution agreement with PanAm for Lodonal™ for sales through its distributor network to hospitals, pharmacists and doctors in Malawi.  The Company has received an initial purchase order for $150,000 and by the agreement, PanAm seeks to distribute a minimum of 5,000 pills per month for the balance of the year with sales expected to increase in 2015.  TNI BioTech and Airmed will deliver the first shipment by July 7, 2014.  TNI BioTech and Airmed estimate that the agreement will generate approximately $1,800,0
http://bit.ly/1sEQ67J